Lifecore Biomedical, Inc. (LFCR) vs MacroGenics, Inc. (MGNX)
Over the past 10 years, MGNX lagged LFCR — -18.75% vs -6.99% annualized total return (price plus dividends).
A side-by-side comparison of Lifecore Biomedical, Inc. and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — LFCR vs MGNX
growth of $100 · dividends reinvested · last 10yMetrics side by side
Did MGNX beat LFCR?
Over the past 10 years, MGNX lagged LFCR — -18.75% vs -6.99% annualized total return (price plus dividends).
Total return (annualized)
| Metric | LFCR | MGNX |
|---|---|---|
| Total return (1Y) | -6.56% | 111.04% |
| Total return CAGR (3Y) | -1.05% | -7.61% |
| Total return CAGR (5Y) | -7.12% | -28.42% |
| Total return CAGR (10Y) | -6.99% | -18.75% |
LFCR is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has MGNX beaten LFCR?
- Over the past 10 years, MGNX lagged LFCR — -18.75% vs -6.99% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.